301 related articles for article (PubMed ID: 28522304)
1. Left Atrial Appendage Occlusion With the LAmbre Device: Initial Experience.
Cruz-González I; Freixa X; Fernández-Díaz JA; Moreno-Samos JC; Martín-Yuste V; Goicolea J
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):755-756. PubMed ID: 28522304
[No Abstract] [Full Text] [Related]
2. Lifetech LAmbre: a new promising and novel device in the interventional stroke prevention.
Schnupp S; Ajmi I; Brachmann J; Mahnkopf C
Future Cardiol; 2019 Nov; 15(6):405-410. PubMed ID: 31710249
[TBL] [Abstract][Full Text] [Related]
3. Computed Tomography-X Ray Fusion in Left Atrial Appendage Closure.
Barreiro-Pérez M; Cruz-González I; Sánchez PL
Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):867. PubMed ID: 28274702
[No Abstract] [Full Text] [Related]
4. Percutaneous left atrial appendage closure is not ready for routine clinical use.
Mandrola J; Foy A; Naccarelli G
Heart Rhythm; 2018 Feb; 15(2):298-301. PubMed ID: 29030233
[No Abstract] [Full Text] [Related]
5. Strategies to balance stroke and bleeding risk in patients with atrial fibrillation and cancer.
Bagga S; Dani SS; Hook BG; Nohria A; Ganatra S
Heart Rhythm; 2021 Sep; 18(9):1533-1538. PubMed ID: 33930550
[No Abstract] [Full Text] [Related]
6. First-in-human experience with the Cardia Ultraseal left atrial appendage closure device: The feasibility study.
Sabiniewicz R; Hiczkiewicz J; Wańczura P; Stecko W; Curzytek A
Cardiol J; 2016; 23(6):652-654. PubMed ID: 27976795
[No Abstract] [Full Text] [Related]
7. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
Raghuram P; Pavithran S; Sivakumar K
Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage closure devices: A reasonable therapeutic alternative.
Reddy VY
Heart Rhythm; 2018 Feb; 15(2):302-305. PubMed ID: 29030234
[No Abstract] [Full Text] [Related]
9. Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation.
Asmarats L; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):440-442. PubMed ID: 30670356
[No Abstract] [Full Text] [Related]
10. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.
Safavi-Naeini P; Rasekh A
Tex Heart Inst J; 2018 Jun; 45(3):172-174. PubMed ID: 30072856
[No Abstract] [Full Text] [Related]
11. Evidence and Indications for Percutaneous Closure of the Left Atrial Appendage.
Segers VFM; Heidbuchel H
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):700-702. PubMed ID: 29653775
[No Abstract] [Full Text] [Related]
12. First-in-man percutaneous closure of left atrial appendage using the Ultraseal II device.
Cruz-González I; González Ferreiro R; Barreiro Pérez M; Sánchez Fernández PL
EuroIntervention; 2019 Oct; 15(9):e816-e817. PubMed ID: 31062693
[No Abstract] [Full Text] [Related]
13. Brain natriuretic peptide levels variation after left atrial appendage occlusion.
Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL
Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157
[TBL] [Abstract][Full Text] [Related]
14. Large Left-Atrial Appendage Occlusion With 2 Simultaneous LAmbre Devices: The More, the Better?
Cruz-González I; Trejo-Velasco B; Barreiro-Pérez M; Núñez JC; González-Ferreiro R; Rodríguez-Collado J; Sánchez PL
Can J Cardiol; 2020 Jun; 36(6):968.e15-968.e16. PubMed ID: 32404290
[No Abstract] [Full Text] [Related]
15. Left Atrial Appendage Occlusion: A Narrative Review.
Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
[TBL] [Abstract][Full Text] [Related]
16. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview.
Masoudi FA; Calkins H; Kavinsky CJ; Drozda JP; Gainsley P; Slotwiner DJ; Turi ZG
Heart Rhythm; 2015 Oct; 12(10):e122-36. PubMed ID: 26134035
[No Abstract] [Full Text] [Related]
17. Safety and Effectiveness of Percutaneous Closure of Left Atrial Appendage in Patients With Intracranial Hemorrhage.
Cruz-González I; Rama-Merchan JC; Martínez-Peralta S; López-Mesonero L; Rodríguez-Collado J; Sánchez PL
Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):58-60. PubMed ID: 27720416
[No Abstract] [Full Text] [Related]
18. Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Gras D; Mansourati J; Deharo JC; Montalescot G; Defaye P
J Am Coll Cardiol; 2019 May; 73(20):2638-2640. PubMed ID: 31118155
[No Abstract] [Full Text] [Related]
19. Left Atrial Appendage Occlusion: The Current Device Landscape and Future Perspectives.
Cruz-Gonzalez I; Fuertes-Barahona M; Moreno-Samos JC; Gonzalez-Ferreiro R; Lam YY; Sanchez PL
Interv Cardiol Clin; 2018 Apr; 7(2):253-265. PubMed ID: 29526293
[TBL] [Abstract][Full Text] [Related]
20. Left Atrial Appendage Exclusion for Atrial Fibrillation.
Syed FF; DeSimone CV; Friedman PA; Asirvatham SJ
Heart Fail Clin; 2016 Apr; 12(2):273-97. PubMed ID: 26968671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
